Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental function
Science Advances · 2025
DOI: 10.1126/sciadv.adr5086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Monika Haoui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA. Hauptthemen laut MEDLINE: Potassium Channels, Inwardly Rectifying, Placenta, Progesterone, Uterus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Preterm birth is detrimental to the well-being of both the mother and the newborn. During normal gestation, the myometrium is maintained in a quiescent state by progesterone. As a steroid hormone, progesterone is thought to modify uterine and placental morphology by altering gene expression, but another direct mode of action has long been suspected. Here, we reveal the nongenomic molecular mechanism of progesterone as the activation of human and murine inwardly rectifying potassium channel Kir7.1, which is expressed in myometrium and placental pericytes during late gestation. Kir7.1 is also activated by selective steroids, including those used to prevent premature labor, such as 17-α-hydroxyprogesterone caproate and dydrogesterone, revealing their unexpected mode of action. Our results reveal that Kir7.1 is the molecular target of both endogenous and synthetic steroids that control uterine excitability and placental function. Kir7.1, therefore, is a promising therapeutic target to support healthy pregnancy during mid and late gestation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
- Center for the Investigation of Membrane Excitability Diseases (CIMED), WashU Medicine; Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.
- Department of Chemosensation, Institute for Biology II, RWTH Aachen University, 52074 Aachen, Germany.
- Department of Neuroepigenetics, Institute for Biology II, RWTH Aachen University, 52074 Aachen, Germany.
ORCID-Profile: Monika Haoui, Citlalli Vergara, Lina Kenzler, Jerome Schröer, Geraldine Zimmer-Bensch, David Fleck, Christopher Wiesbrock, Marc Spehr, Polina V Lishko
Förderung
- NIA NIH HHS
Zitieren
APA
Haoui, M., Vergara, C., Kenzler, L., Schröer, J., Zimmer-Bensch, G., Fleck, D., Wiesbrock, C., Spehr, M., & Lishko, P. V. (2025). Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental function. Science Advances. https://doi.org/10.1126/sciadv.adr5086
Vancouver
Haoui M, Vergara C, Kenzler L, Schröer J, Zimmer-Bensch G, Fleck D, et al. Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental function. Science Advances. 2025. doi:10.1126/sciadv.adr5086
BibTeX
@article{Haoui2025,
author = {Haoui, Monika and Vergara, Citlalli and Kenzler, Lina and Schröer, Jerome and Zimmer-Bensch, Geraldine and Fleck, David and Wiesbrock, Christopher and Spehr, Marc and Lishko, Polina V},
title = {Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental function},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr5086}
}
EUVIMED